Clinical trial

Study on the Mechanism of Yifei Moxibustion Improving Immune Function in COPD Based on Plasma Exosome miRNAs

NCT07131020

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BEHAVIORAL · Unmapped registry intervention Yifei moxibustion Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Conventional Western medicine treatment Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention TCM syndrome differentiation treatment Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study on the Mechanism of Yifei Moxibustion Improving Immune Function in COPD Based on Plasma Exosome miRNAs

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-05-11

PhaseNA

Conditions

Stable COPD Patientsunresolved

Interventions

Yifei moxibustionBEHAVIORAL

Conventional Western medicine treatmentDRUG

TCM syndrome differentiation treatmentDRUG

Sponsors & collaborators

Henan University of Traditional Chinese Medicinelead sponsor

Mapped research locations

ZhengzhouHenan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07131020 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.